0016-3813
0016-3813
S0016-38132021001100001
10.24875/gmm.m21000569
México
México
México
México
México
México
México
México
México
México
México
México
00
00
2021
00
00
2021
157
spe1
1
11
[
Ovarian Cancer V.1.2021
]
[
2020
371
m3773
]
[
2019
144
1941-53
]
[
2019
37
2386-97
]
[
2016
17
1579-89
]
[
2009
3
CD004706
]
[
2015
12
CD004706
]
[
2014
25
1165-71
]
[
2013
24
Suppl 6
Suppl 6
vi24-32
]
[
2010
116
301-6
]
[
2019
30
672-705
]
[
2013
128
1
1
6-11
]
[
2019
37
2383-5
]
[
2019
37
1380-90
]
[
2006
354
34-43
]
[
2018
Suppl 2
29-30
]
[
2018
378
230-40
]
[
2020
32
451-8
]
[
2021
47
101-7
]
[
2013
14
1020-6
]
[
2014
15
396-405
]
[
2016
374
738-48
]
[
2018
125
30-4
]
[
2016
34
3460-73
]
[
2020
8
1710
]
[
2010
363
943-53
]
[
2013
49
3191-201
]
[
2015
386
249-57
]
[
2016
64
22-31
]
[
2018
19
1680-7
]
[
2002
55
348-59
]
[
2011
365
2473-83
]
[
2011
365
2484-96
]
[
2013
131
21-6
]
[
2018
36
Suppl 15
Suppl 15
]
[
2013
8
]
[
2019
11
4371-90
]
[
Olaparib
]
[
2018
379
2495-505
]
[
2019
381
2416-28
]
[
2019
140
28-38
]
[
2019
37
2424-36
]
[
2019
69
280-304
]
[
2003
361
2099-106
]
[
2010
28
3323-9
]
[
2019
11
3061-78
]
[
2012
30
2039-45
]
[
2017
18
779-91
]
[
2018
36
Suppl 15
Suppl 15
5506
]
[
2012
366
1382-92
]
[
2014
15
852-61
]
[
2017
18
1274-84
]
[
2019
155
585-9
]
[
2020
20
90
]
[
2017
390
1949-61
]
[
2016
375
2154-64
]
[
2016
10
35-41
]
[
2014
32
1302-8
]
[
2015
33
244-50
]
[
2017
147
267-75
]
[
2019
20
636-48
]
[
2015
33
4015-22
]
[
]